Prevention and treatment of amyloidogenic disease
First Claim
Patent Images
1. A pharmaceutical composition comprising Aβ
- or an immunogenic fragment thereof presented by a virus or bacteria as part of an immunogenic composition effective to induce an immunogenic response comprising antibodies against Aβ
in a patient.
7 Assignments
0 Petitions
Accused Products
Abstract
The invention provides compositions and methods for treatment of amyloidogenic diseases. Such methods entail administering an agent that induces a beneficial immune response against an amyloid deposit in the patient. The methods are particularly useful for prophylactic and therapeutic treatment of Alzheimer'"'"'s disease. In such methods, a suitable agent is Aβ peptide or an antibody thereto.
173 Citations
28 Claims
-
1. A pharmaceutical composition comprising Aβ
- or an immunogenic fragment thereof presented by a virus or bacteria as part of an immunogenic composition effective to induce an immunogenic response comprising antibodies against Aβ
in a patient. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8)
- or an immunogenic fragment thereof presented by a virus or bacteria as part of an immunogenic composition effective to induce an immunogenic response comprising antibodies against Aβ
-
9. A method of treating a disease characterized by an amyloid deposit of Aβ
- in a patient, comprising administering to a patient having the disease an effective dosage of Aβ
or an immunogenic fragment thereof presented by a virus or bacteria, wherein the Aβ
or the immunogenic fragment thereof induces an immune response comprising antibodies against Aβ and
thereby treating the disease. - View Dependent Claims (10, 11, 12, 13, 14, 15, 16, 17, 18)
- in a patient, comprising administering to a patient having the disease an effective dosage of Aβ
-
19. A method of prophylaxis of a disease characterized by an amyloid deposit of Aβ
- in a patient, comprising administering to a patient susceptible to the disease an effective dosage of Aβ
or an immunogenic fragment thereof presented by a virus or bacteria, wherein the Aβ
or the immunogenic fragment thereof induces an immune response comprising antibodies against Aβ and
thereby effecting prophylaxis of the disease. - View Dependent Claims (20, 21, 22, 23, 24, 25, 26, 27, 28)
- in a patient, comprising administering to a patient susceptible to the disease an effective dosage of Aβ
Specification